IP Library Granted Patent US 12,668,588
Granted Patent B2
US 12,668,588 · App. 18/004,147 · Granted Jun 30, 2026

Method for preparing intermediate of uracil compound containing isoxazoline

Inventors: Enming Wu (Shenyang, CN); Gongxin Wu (Shenyang, CN); Chunrui Yu (Shenyang, CN); Qiao Wu (Shenyang, CN); Jichun Yang (Shenyang, CN); Yanming Ye (Shenyang, CN); Fuqiang Yu (Shenyang, CN); Youren Xue (Shenyang, CN); Aiying Guan (Shenyang, CN)
Assignees: SHENYANG SINOCHEM AGROCHEMICALS R&D CO., LTD.; JIANGSU YANGNONG CHEMICAL CO., LTD.
C07D413/10B01J31/0244
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,668,588
App. No.
18/004,147
Granted
Jun 30, 2026
Kind
B2
Abstract

A method for preparing an intermediate of a uracil compound containing isooxazoline includes the steps of: making 3-amino-4,4,4-trifluorocrotonic acid methyl ester react with substituted aryl carbamate; in a reaction process, continuously evaporating water and byproduct alcohol in the system; and conducting processing to obtain the intermediate of the uracil compound containing isooxazoline. Using this method the selectivity of the reaction and the utilization rate of raw materials are improved; the hydrolysis products, impurities and tar are reduced; the reaction time is greatly shortened; and the productivity is improved. After one recrystallization of crude products, an intermediate product with purity of more than 97% can be obtained, and quantitative yield can be more than 85%.

Claims (32)

1 . A method for preparing an intermediate of a uracil compound containing isooxazoline, comprising:

reacting a compound of formula III with a compound of formula IV in the presence of a catalyst; and

continuously removing water and alcohol generated in the reaction by evaporation to obtain the intermediate of the uracil compound containing isooxazoline of formula II:

wherein:

R 1 and R 2 are the same or different, and are independently selected from hydrogen, fluorine, and chlorine;

R 3 is hydrogen or C 1 -C 4 alkyl;

R 4 is hydrogen, CO 2 R 7 , or CH 2 OR 8 ;

R 5 is hydrogen, CO 2 R 7 , or CH 2 OR 8 ;

R 6 is hydrogen, C 1 -C 4 alkyl, or C 1 -C 4 haloalkyl;

R 7 is C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, allyl, or propargyl;

R 8 is hydrogen, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, or C 1 -C 4 alkyl carbonyl;

R 9 is C 1 -C 4 alkyl;

R 10 is C 1 -C 4 alkyl, and

the catalyst is 1,8-diazabicyclo[5.4.0]undec-7-ene or a salt thereof.

2 . The method for preparing the intermediate of the uracil compound containing isooxazoline according to claim 1 , wherein:

R 1 and R 2 are the same or different, and are independently selected from hydrogen, fluorine, and chlorine;

R 3 is hydrogen or C 1 -C 4 alkyl;

R 4 is hydrogen;

R 5 is CO 2 R 7 ;

R 6 is C 1 -C 4 haloalkyl;

R 7 is selected from methyl, ethyl, n-propyl, n-butyl, isopropyl, isobutyl, tert-butyl, trifluoroethyl, allyl, and propargyl;

R 9 is methyl or ethyl; and

R 10 is methyl or ethyl.

3 . The method for preparing the intermediate of the uracil compound containing isooxazoline according to claim 1 , wherein the reaction is carried out in the presence of an alkali, and a molar ratio of the alkali to the compound of formula III is 0.5:1-3:1.

4 . The method for preparing the intermediate of the uracil compound containing isooxazoline according to claim 1 , wherein an amount of the catalyst is 0.001%-10% of a weight of the compound of formula III.

5 . The method for preparing the intermediate of the uracil compound containing isooxazoline according to claim 4 , wherein the amount of the catalyst is 0.1%- 5% of the weight of the compound of formula III.

6 . The method for preparing the intermediate of the uracil compound containing isooxazoline according to claim 3 , wherein the alkali is one or two selected from the group consisting of potassium carbonate, sodium carbonate, cesium carbonate, potassium bicarbonate, sodium bicarbonate, and cesium bicarbonate.

7 . The method for preparing the intermediate of the uracil compound containing isooxazoline according to claim 6 , wherein the alkali is one or two selected from the group consisting of potassium carbonate, sodium carbonate, potassium bicarbonate and sodium bicarbonate, wherein a molar ratio of the alkali to the compound of formula III is 0.5:1-2:1.

8 . The method for preparing the intermediate of the uracil compound containing isooxazoline according to claim 1 , wherein the reaction is carried out in the presence of a water carrying agent or a mixed solvent that is 2-20 times a weight of the compound of formula III, and the mixed solvent comprises the water carrying agent and a polar aprotic solvent, wherein a weight of the polar aprotic solvent is 20%- 70% of the weight of the mixed solvent.

9 . The method for preparing the intermediate of the uracil compound containing isooxazoline according to claim 8 , wherein the reaction is carried out in the presence of a water carrying agent selected from the group consisting of n-propyl acetate, isopropyl acetate, n-butyl acetate, methyl isopropyl ketone, methyl isobutyl ketone, ethylene glycol dimethyl ether, ethylene glycol diethyl ether, 2-methyl tetrahydrofuran, and acetonitrile; and the mixed solvent comprises a compound selected from the group consisting of toluene, chlorobenzene, n-propyl acetate, isopropyl acetate, methyl isopropyl ketone, methyl isobutyl ketone, ethylene glycol dimethyl ether, ethylene glycol diethyl ether, 2-methyltetrahydrofuran, and acetonitrile; and the polar aprotic solvent in the mixed solvent is N,N-dimethylformamide, dimethyl sulfoxide, or N-methylpyrrolidone.

10 . A method for production of a compound of formula I, comprising: producing a compound of formula II using a method according to claim 1 , and converting the compound of formula II to obtain the compound of formula I,

11 . The method for preparing the intermediate of the uracil compound containing isooxazoline according to claim 8 , wherein the mixed solvent comprises a compound selected from the group consisting of toluene, chlorobenzene, n-propyl acetate, isopropyl acetate, methyl isopropyl ketone, methyl isobutyl ketone, ethylene glycol dimethyl ether, ethylene glycol diethyl ether, 2-methyltetrahydrofuran, and acetonitrile; and the polar aprotic solvent in the mixed solvent is N,N-dimethylformamide, dimethyl sulfoxide, or N-methylpyrrolidone.